KONG SUN HOLD (00295) announces a net loss of approximately 215 million yuan attributable to equity shareholders in 2025, a year-on-year decrease of 58.83%.
Jiangshan Holdings (00295) announced its performance in 2025, with a continuous operating revenue of approximately 321 million yuan, a decrease of 18.21% year-on-year; net loss attributable to equity shareholders of the company was approximately 215 million yuan, a 58.83% narrower year-on-year; loss per share was 1.44 cents.
Kong Sun Hold (00295) announced its performance for the year 2025, with a revenue from continued operations of approximately 321 million yuan, a decrease of 18.21% year-on-year; the company's equity shareholders' share of losses is about 215 million yuan, a narrower decrease of 58.83% year-on-year; resulting in a loss per share of 1.44 cents.
The announcement stated that the decrease in revenue was due to (i) a 60% stake sale of business in April 2024, leading to a reduction in revenue from providing operation and maintenance services for CECEP Solar Energy power plants; and (ii) a decrease in electricity sales revenue.
Related Articles

NC Healthcare (01518) released its annual performance, reporting a net loss of 115 million yuan attributable to shareholders, a turnaround from profit to loss compared to the previous year.

SOFTMEDX (00648) released its annual performance, with a net profit of HK$6.95 million, a decrease of 97.87% year-on-year.

LAI SUN INT'L (00191) announced its interim financial results, with a net loss attributable to shareholders of HK$682 million, representing a 453.4% increase year-on-year.
NC Healthcare (01518) released its annual performance, reporting a net loss of 115 million yuan attributable to shareholders, a turnaround from profit to loss compared to the previous year.

SOFTMEDX (00648) released its annual performance, with a net profit of HK$6.95 million, a decrease of 97.87% year-on-year.

LAI SUN INT'L (00191) announced its interim financial results, with a net loss attributable to shareholders of HK$682 million, representing a 453.4% increase year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


